fda approval ghk cu drug status ghk-cu ghk-cu peptide fda approval status GHK-CU Peptide Is GHK-Cu FDA-Approved? - News
Description
Myelinolytic lesions in spinal cord of cobalamin-deficient rats are TNF-alpha-mediated
One such concern is the release of a thiol intermediate
Nat Rev Neurol 21 , 687705 (2025)
Please consult with your physician or other qualified healthcare professional before acting on any information presented here
